As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

CombiMatrix

  • Thursday's Range: $4.23-$4.42
  • 52-Week Range: $4.00-$32.40
  • Thursday's Volume: 16,000
  • Three-Month Average Volume: 9,648

CombiMatrix  (CBMX)  provides molecular diagnostic solutions and clinical support services. This stock closed up 2.8% to $4.36 in Thursday's trading session.

From a technical perspective, CombiMatrix trended up notably higher on Thursday right above its new 52-week low of $4 a share with above-average volume. This high-volume spike to the upside is now quickly pushing shares of CombiMatrix within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take Thursday's intraday high of $4.45 a share and then once it clears some key near-term overhead resistance at $4.48 a share with high volume.

Traders should now look for long-biased trades in CombiMatrix as long as it's trending above its new 52-week low of $4 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 9,648 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $4.97 to $6 a share.

Marinus Pharmaceuticals

  • Thursday's Range: $4.46-$4.79
  • 52-Week Range: $4.00-$20.72
  • Thursday's Volume: 40,000
  • Three-Month Average Volume: 93,957

Marinus Pharmaceuticals  (MRNS) , a clinical stage biopharmaceutical company, focuses on developing and commercializing neuropsychiatric therapeutics. This stock traded up 7% to $4.70 in Thursday's trading session.

From a technical perspective, Marinus Pharmaceuticals trended sharply higher on Thursday back above its 20-day moving average of $4.56 a share with lighter-than-average volume. This stock recently formed a triple bottom chart pattern, after shares found some buying interest at $4.00, $4.01 and $4.00 a share. Following that potential bottom, shares of Marinus Pharmaceuticals have started to trend higher back above its 20-day moving average, and it's now quickly moving within range of triggering a major breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $4.88 to $5 a share with high volume.

Traders should now look for long-biased trades in Marinus Pharmaceuticals s as long as it's trending above those triple bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 93,957 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5.35 to $5.50, or even its 50-day moving average of $5.76 to $6.14 a share.

Civeo

  • Thursday's Range: $0.90-$1.04
  • 52-Week Range: $0.75-$4.96
  • Thursday's Volume: 1.34 million
  • Three-Month Average Volume: 988,948

Civeo  (CVEO)  provides remote site accommodation, logistics and facility management services to the natural resource industry in Australia, Canada and the U.S. This stock traded up 8.4 to $1.01 in Thursday's trading session.

From a technical perspective, Civeo ripped sharply higher on Thursday right off some near-term support at 90 cents per share and back above its 20-day moving average of 93 cents per share with strong upside volume flows. This move briefly pushed this stock into breakout territory, after shares tested some near-term overhead resistance at $1.02 a share. Market players should now look for a continuation move to the upside in the short-term if shares of Civeo manage to take out Thursday's intraday high of $1.04 and then once it clears its 50-day moving average of $1.10 a share with high volume.

Traders should now look for long-biased trades in Civeo as long as it's trending above some near-term support at 88 cents per share and then once it sustains a move or close above $1.04 to $1.10 a share with volume that hits near or above 988,948 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $1.20 to $1.28, or even $1.40 to $1.50 a share.

Aratana Therapeutics

  • Thursday's Range: $3.61-$3.98
  • 52-Week Range: $2.56-$20.63
  • Thursday's Volume: 716,000
  • Three-Month Average Volume: 593,810

Aratana Therapeutics  (PETX) , a development-stage biopharmaceutical company, focuses on the licensing, development and commercialization of biopharmaceutical products for the companion animals worldwide. This stock traded up 10% to $3.96 in Thursday's trading session.

From a technical perspective, Aratana Therapeutics ripped sharply higher on Thursday and broke out above some near-term overhead resistance levels at $3.68 a share to its 50-day moving average of $3.80 a share with strong upside volume flows. This high-volume breakout is now quickly pushing this stock within range of triggering another big breakout trade. That trade will trigger if shares of Aratana Therapeutics manages to take out Thursday's intraday high of $3.98 a share to some more key resistance at $4.19 a share with high volume.

Traders should now look for long-biased trades in Aratana Therapeutics as long as it's trending above Thursday's intraday low of $3.61 a share or above its 20-day moving average of $3.23 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 593,810 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.75, or even $5 to $5.20 a share.

Synergy Pharmaceuticals

Synergy Pharmaceuticals  (SGYP) , a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal disorders and diseases. This stock traded up 2% to $3.48 in Thursday's trading session.

  • Thursday's Range: $3.38-$3.54
  • 52-Week Range: $3.03-$10.15
  • Thursday's Volume: 1.46 million
  • Three-Month Average Volume: 2.10 million

From a technical perspective, Synergy Pharmaceuticals trended modestly higher on Thursday right above some near-term support at $3.25 a share with lighter-than-average volume. This stock has been uptrending a bit over the last few trading sessions, with shares moving higher off its new 52-week low of $3.03 a share to its intraday high on Thursday of $3.54 a share. During that move, shares of Synergy Pharmaceuticals have been consistently making higher lows and higher highs, which is bullish technical price action. Market players should now look for a continuation move to the upside in the short-term if this stock manages to clear its 20-day moving average of $3.56 a share with strong volume.

Traders should now look for long-biased trades in Synergy Pharmaceuticals as long as it's trending above some near-term support at $3.25 a share and then once it sustains a move or close above its 20-day moving average of $3.56 a share with volume that hits near or above 2.10 million shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $3.80 to $4.08, or even its 50-day moving average of $4.15 a share.

Cardiovascular Systems

  • Thursday's Range: $9.22-$9.71
  • 52-Week Range: $7.50-$41.28
  • Thursday's Volume: 680,000
  • Three-Month Average Volume: 564,588

Cardiovascular Systems  (CSII) , a medical technology company, develops, manufactures and markets devices to treat vascular diseases in the U.S. This stock traded up 3% to $9.55 in Thursday's trading session.

From a technical perspective, Cardiovascular Systems spiked notably higher on Thursday with above-average volume flows. This stock has been uptrending strong over the last few weeks, with shares moving higher off its new 52-week low of $7.50 a share to its intraday high on Thursday of $9.71 a share. During that uptrend, this stock has been consistently making higher lows and higher highs, which is bullish technical price action. This high-volume spike to the upside is now quickly pushing shares of Cardiovascular Systems within range of triggering a big breakout trade. That trade will trigger if this stock manages to clear Thursday's intraday high of $9.71 a share and then once it takes out more resistance at $9.95 a share with high volume.

Traders should now look for long-biased trades in Cardiovascular Systems as long as it's trending above its previous breakout level of $9.34 a share or above its 20-day moving average of $8.58 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 564,588 shares. If that breakout materializes soon, then this stock will set up to re-fill some of its previous gap-down-day zone from January that started at $13 a share.

Crestwood Equity Partners

  • Thursday's Range: $8.40-$9.31
  • 52-Week Range: $8.02-$70.10
  • Thursday's Volume: 1.52 million
  • Three-Month Average Volume: 1.25 million

Crestwood Equity Partners  (CEQP)  provides midstream solutions to customers in the crude oil, natural gas liquids and natural gas sectors of the energy industry in the U.S. This stock traded up 2.5% to $8.80 in Thursday's trading session.

From a technical perspective, Crestwood Equity Partners trended notably higher on Thursday right above some near-term support at $8.34 a share with above-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $8.02 to $8.07 a share. Following that potential bottom, shares of Crestwood Equity Partners have now started to spike higher, and it's quickly moving within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $9.50 to its 20-day moving average of $9.71 a share and then above more key support at $9.75 a share with high volume.

Traders should now look for long-biased trades in Crestwood Equity Partners as long as it's trending above some near-term support at $8.34 a share or above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 1.25 million shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $10.84 to $11.82 a share.

Global Power Equipment Group

  • Thursday's Range: $2.76-$2.85
  • 52-Week Range: $2.50-$13.92
  • Thursday's Volume: 122,000
  • Three-Month Average Volume: 79,780

Global Power Equipment Group  (GLPW)  provides custom engineered equipment, and modification and maintenance services to the power infrastructure, energy and process industries worldwide. This stock traded up 2.9% to $2.82 in Thursday's trading session.

From a technical perspective, Global Power Equipment Group trended higher on Thursday right off its 20-day moving average of $2.74 a share with strong upside volume flows. This stock recently formed a triple bottom chart pattern, after shares found some buying interest at $2.59, $2.60 and $2.62 a share. Following that potential bottom, shares of Global Power Equipment Group has now started to trend higher, and it's quickly moving within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $2.98 to its 50-day moving average of $3 a share and then above more resistance at $3.05 a share with high volume.

Traders should now look for long-biased trades in Global Power Equipment Group as long as it's trending above those recent triple bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 79,780 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $3.37, or even $3.50 to $3.86 a share.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

More from Opinion

5 Things to Watch for When Netflix Reports Earnings on Monday

5 Things to Watch for When Netflix Reports Earnings on Monday

Flashback Friday: Bank Stocks Stay Hot and Tesla Stays Relevant

Flashback Friday: Bank Stocks Stay Hot and Tesla Stays Relevant

Throwback Thursday: Tesla's Risky, Broadcom Slips, Papa John's Jumps

Throwback Thursday: Tesla's Risky, Broadcom Slips, Papa John's Jumps

Apple's 2018 Macs and iPads Could Prove Strong Enough to Lift Flagging Sales

Apple's 2018 Macs and iPads Could Prove Strong Enough to Lift Flagging Sales

Does Forbes Know What Self-Made Means? The Internet Says No

Does Forbes Know What Self-Made Means? The Internet Says No